METTL3 and osteoporosis: In vivo and in vitro experiments showed that Cpd-564 could inhibit the expression of METTL3, thereby inhibiting osteoblast senescence and delaying the occurrence and progression of osteoporosis, which is a promising new method for the prevention of osteoporosis (Figure 4).